Table 4.

Standardized Regression Coefficients for Individual Stroke Symptoms and Biomarkers

	Unilateral Numbness (n=77)	Unilateral Painless Weakness (n=66)	Hemifield Vision Loss (n=33)	Painless Loss of Vision in One or Both Eyes (n=51)	Loss of Ability to Understand (n=32)	Loss of Ability to Communicate (n=40)
Cardiac Function
NT-proBNP
Model 1	0.13	0.21*	0.44†	0.28†	0.26*	0.11
Model 2‡	-	0.06 (−0.18-0.30)	0.35 (0.02-0.67)	0.25 (−0.03-0.52)	0.28 (−0.04-0.60)	-
Inflammation
Fibrinogen
Model 1	−0.04	0.15	−0.03	0.15	−0.14	0.22*
Model 2	-	-	-	-	-	0.14 (−0.08-0.36)
CRP
Model 1	0.14	0.00	0.09	0.28†	−0.23	−0.09
Model 2	-	-	-	0.32 (0.09-0.56)	-	-
Coagulation
FXI
Model 1	0.16	0.30†	0.08	0.07	0.12	0.12
Model 2	-	0.24 (−0.02-0.54)	-	-	-	-
D-dimer
Model 1	0.11	0.21*	0.14	0.04	−0.01	0.00
Model 2	-	0.21 (−0.04-0.47)	-	-	-	-

Model 1 Adjusted for age, race and sex.

Model 2. 95% CI is shown in parentheses. Adjusted for age, race, sex, history of heart disease, atrial fibrillation, diabetes mellitus, antihypertensive medication use, current smoking, systolic blood pressure, LVH, lipid lowering medication use and regular aspirin use.

^*p value ≤0.10

^†p value ≤0.05

^‡Model 2 analysis was only performed if the p value for model 1 was <0.10.